These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15253711)

  • 1. Impairment of phenylalanine conversion to tyrosine in end-stage renal disease causing tyrosine deficiency.
    Boirie Y; Albright R; Bigelow M; Nair KS
    Kidney Int; 2004 Aug; 66(2):591-6. PubMed ID: 15253711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A four-compartment compartmental model to assess net whole body protein breakdown using a pulse of phenylalanine and tyrosine stable isotopes in humans.
    Mason A; Engelen MPKJ; Ivanov I; Toffolo GM; Deutz NEP
    Am J Physiol Endocrinol Metab; 2017 Jul; 313(1):E63-E74. PubMed ID: 28270442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenylalanine and tyrosine metabolism in chronic kidney failure.
    Kopple JD
    J Nutr; 2007 Jun; 137(6 Suppl 1):1586S-1590S; discussion 1597S-1598S. PubMed ID: 17513431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral versus intravenous L-phenylalanine loading compared by simultaneous application of L-[2H5] and L-[15N]phenylalanine.
    Lehmann WD; Heinrich HC
    Clin Chim Acta; 1985 Apr; 147(3):261-6. PubMed ID: 3995775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of recombinant human growth hormone on muscle protein turnover in malnourished hemodialysis patients.
    Garibotto G; Barreca A; Russo R; Sofia A; Araghi P; Cesarone A; Malaspina M; Fiorini F; Minuto F; Tizianello A
    J Clin Invest; 1997 Jan; 99(1):97-105. PubMed ID: 9011582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The kidney is an important site for in vivo phenylalanine-to-tyrosine conversion in adult humans: A metabolic role of the kidney.
    Møller N; Meek S; Bigelow M; Andrews J; Nair KS
    Proc Natl Acad Sci U S A; 2000 Feb; 97(3):1242-6. PubMed ID: 10655515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein metabolism in glucagonoma.
    Barazzoni R; Zanetti M; Tiengo A; Tessari P
    Diabetologia; 1999 Mar; 42(3):326-9. PubMed ID: 10096785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine and methionine metabolism in ESRD: A stable isotope study.
    van Guldener C; Kulik W; Berger R; Dijkstra DA; Jakobs C; Reijngoud DJ; Donker AJ; Stehouwer CD; De Meer K
    Kidney Int; 1999 Sep; 56(3):1064-71. PubMed ID: 10469375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein metabolism in Turner syndrome and the impact of hormone replacement therapy.
    Gravholt CH; Riis AL; Møller N; Christiansen JS
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):413-8. PubMed ID: 17561982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenylalanine and tyrosine kinetics in compensated liver cirrhosis: effects of meal ingestion.
    Tessari P; Kiwanuka E; Vettore M; Barazzoni R; Zanetti M; Cecchet D; Orlando R
    Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G598-604. PubMed ID: 18653725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereospecificity of phenylalanine plasma kinetics and hydroxylation in man following oral application of a stable isotope-labelled pseudo-racemic mixture of L- and D-phenylalanine.
    Lehmann WD; Theobald N; Fischer R; Heinrich HC
    Clin Chim Acta; 1983 Mar; 128(2-3):181-98. PubMed ID: 6851137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenylalanine and tyrosine kinetics for different patterns and indispensable amino acid intakes in adult humans.
    Marchini JS; Cortiella J; Hiramatsu T; Castillo L; Chapman TE; Young VR
    Am J Clin Nutr; 1994 Jul; 60(1):79-86. PubMed ID: 8017342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolic conversion of phenylalanine into tyrosine in the human kidney: does it have nutritional implications in renal patients?
    Garibotto G; Tessari P; Verzola D; Dertenois L
    J Ren Nutr; 2002 Jan; 12(1):8-16. PubMed ID: 11823989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamine kinetics and protein turnover in end-stage renal disease.
    Raj DS; Welbourne T; Dominic EA; Waters D; Wolfe R; Ferrando A
    Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E37-46. PubMed ID: 15265763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The conversion of phenylalanine to tyrosine in man. Direct measurement by continuous intravenous tracer infusions of L-[ring-2H5]phenylalanine and L-[1-13C] tyrosine in the postabsorptive state.
    Clarke JT; Bier DM
    Metabolism; 1982 Oct; 31(10):999-1005. PubMed ID: 7132735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment of phenylalanine hydroxylation in chronic renal insufficiency.
    Young GA; Parsons FM
    Clin Sci; 1973 Jul; 45(1):89-97. PubMed ID: 4719186
    [No Abstract]   [Full Text] [Related]  

  • 17. Phenylalanine and tyrosine metabolism in renal failure: dipeptides as tyrosine source.
    Druml W; Roth E; Lenz K; Lochs H; Kopsa H
    Kidney Int Suppl; 1989 Nov; 27():S282-6. PubMed ID: 2517676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma free amino acids and their metabolites in Taiwanese patients on hemodialysis and continuous ambulatory peritoneal dialysis.
    Chuang CK; Lin SP; Chen HH; Chen YC; Wang TJ; Shieh WH; Wu CJ
    Clin Chim Acta; 2006 Feb; 364(1-2):209-16. PubMed ID: 16087168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed plasma clearance of phenylalanine and tyrosine in elderly men.
    Rudman D; Abbasi AA; Chaudry F; Mattson DE
    J Am Geriatr Soc; 1991 Jan; 39(1):33-8. PubMed ID: 1898955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homocysteine clearance and methylation flux rates in health and end-stage renal disease: association with S-adenosylhomocysteine.
    Stam F; van Guldener C; ter Wee PM; Kulik W; Smith DE; Jakobs C; Stehouwer CD; de Meer K
    Am J Physiol Renal Physiol; 2004 Aug; 287(2):F215-23. PubMed ID: 15271686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.